ArticleJournal of cancer research and clinical oncology2019

CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.

Vivek Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.